Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $1.67 Million - $2.23 Million
19,019 Added 281.26%
25,781 $2.51 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $157,085 - $210,850
1,941 Added 40.26%
6,762 $699,000
Q3 2022

Nov 14, 2022

SELL
$82.16 - $96.94 $603,300 - $711,830
-7,343 Reduced 60.37%
4,821 $409,000
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $431,310 - $524,052
6,034 Added 98.43%
12,164 $1.01 Million
Q1 2022

May 16, 2022

SELL
$74.28 - $92.69 $295,114 - $368,257
-3,973 Reduced 39.32%
6,130 $473,000
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $724,587 - $924,121
10,103 New
10,103 $893,000
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $917,597 - $1.03 Million
-12,152 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $908,118 - $1.1 Million
12,152 New
12,152 $918,000
Q2 2020

Aug 14, 2020

SELL
$79.55 - $124.22 $634,809 - $991,275
-7,980 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$71.37 - $96.85 $569,532 - $772,863
7,980 New
7,980 $674,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.